Advertisement
Screener

Atlassian Corporation (TEAM) Spending and interest coverage

Atlassian Corporation (TEAM) Spending and interest coverage

  • R&D / revenue · 12 months: Value 49.74%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
  • Stock-based compensation / revenue · 12 months: Value 24.44%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
  • Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..

Spending and interest coverage

Overview →

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
R&D / revenue · 12 months49.74%Research and development expense / revenue. Period ending 2026-06-30.

$3.27B ÷ $6.57B × 100 ≈ 49.74%

Stock-based compensation / revenue · 12 months24.44%Share-based compensation / revenue. Period ending 2026-06-30.

$1.61B ÷ $6.57B × 100 ≈ 24.44%

Interest coverage · 12 months(m)Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Research and development spending3.27B USDResearch and Development Expense
Revenue6.57B USDRevenue from Contract with Customer, Excluding Assessed Tax
Stock-based compensation1.61B USDShare-based Payment Arrangement, Noncash Expense
Operating income10.36M USDOperating Income (Loss)
Interest expense · reported / estimated(m)Interest Expense · Estimated expense assumptions

Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingResearch and development spending (USD)Revenue (USD)Stock-based compensation (USD)Operating income (USD)Interest expense · reported / estimated (USD)R&D / revenueSBC / revenueInterest coverageInterest expense basis
2026-06-30$3.27B$6.57B$1.61B$10.36M(m)49.74%24.44%(m)(m)
2026-03-31$3.21B$6.19B$1.56B$-228.85M(m)51.86%25.24%(m)(m)
2025-12-31$2.97B$5.76B$1.50B$-185.02M(m)51.54%26.06%(m)(m)
2025-09-30$2.82B$5.46B$1.43B$-194.75M(m)51.69%26.14%(m)(m)
2025-06-30$2.67B$5.22B$1.36B$-130.39M(m)51.18%26.12%(m)(m)
2025-03-31$2.56B$4.96B$1.29B$-168.86M(m)51.54%25.90%(m)(m)
2024-12-31$2.45B$4.79B$1.22B$-138.60M(m)51.07%25.46%(m)(m)
2024-09-30$2.31B$4.57B$1.13B$-130.19M(m)50.46%24.78%(m)(m)
2024-06-30$2.18B$4.36B$1.08B$-117.08M(m)50.11%24.81%(m)(m)
2024-03-31$2.07B$4.17B$1.05B$-100.52M$34.97M49.68%25.28%-2.87×Reported
2023-12-31$2.02B$3.89B$1.03B$-279.89M$34.49M51.79%26.57%-8.11×Reported
2023-09-30$1.95B$3.71B$1.01B$-330.06M$33.00M52.70%27.26%-10.00×Reported
2023-06-30$1.87B$3.53B$948.09M$-345.22M$30.15M52.90%26.82%-11.45×Reported
2023-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2022-12-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2022-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2022-06-30$1.29B$2.80B$524.80M$70.08M$41.47M46.09%18.72%1.69×Reported
2022-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-12-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-06-30$932.99M$2.09B$340.82M$141.41M$92.59M44.66%16.31%1.53×Reported

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.